Metformin for Lithium-induced Weight Gain: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Lithium is the first line treatment for maintenance treatment of bipolar disorder. Among the long term adverse effects, weight gain is likely to affect a subset of patients. There is no specific guideline for the treatment of lithium-induced weight gain. We report a young male with bipolar disorder who had significant weight gain with lithium (25 kg), which responded to metformin treatment at 500 mg twice daily. The proposed mechanism of weight lowering effect of metformin includes changes in hypothalamic physiology, including leptin and insulin sensitivity, as well as circadian rhythm changes affecting food intake, regulation of fat oxidation and storage in liver, skeletal muscle, and adipose tissue.
Abstract
Lithium is the first line treatment for maintenance treatment of bipolar disorder. Among the long term adverse effects, weight gain is likely to affect a subset of patients. There is no specific guideline for the treatment of lithium-induced weight gain. We report a young male with bipolar disorder who had significant weight gain with lithium (25 kg), which responded to metformin treatment at 500 mg twice daily. The proposed mechanism of weight lowering effect of metformin includes changes in hypothalamic physiology, including leptin and insulin sensitivity, as well as circadian rhythm changes affecting food intake, regulation of fat oxidation and storage in liver, skeletal muscle, and adipose tissue.
참고문헌 (22)
- Coryell W, "Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice", Bipolar Disord, 11(Suppl 2), pp.77~83 (2009)
- McKnight RF, "Lithium toxicity profile: a systematic review and meta-analysis", Lancet, 379, pp.721~728 (2012)
- Garland EJ, "Weight gain with antidepressants and lithium", J Clin Psychopharmacol, 8, pp.323~330 (1988)
- Baptista T, "Lithium and body weight gain", Pharmacopsychiatry, 28, pp.35~44 (1995)
- Torrent C, "Weight gain in bipolar disorder: pharmacological treatment as a contributing factor", Acta Psychiatr Scand, 118, pp.4~18 (2008)
- Vendsborg PB, "Lithium treatment and weight gain", Acta Psychiatr Scand, 53, pp.139~147 (1976)
- Chengappa KN, "Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review", Clin Ther, 24, pp.1576~1584 (2002)
- Coxhead N, "Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder", Acta Psychiatr Scand, 85, pp.114~118 (1992)
- Hasnain M, "Weight considerations in psychotropic drug prescribing and switching", Postgrad Med, 125, pp.117~129 (2013)
- Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
- Vendsborg PB, "Fat cell number and weight gain in lithium treated patients", Acta Psychiatr Scand, 53, pp.355~359 (1976)
- Atmaca M, "Weight gain and serum leptin levels in patients on lithium treatment", Neuropsychobiology, 46, pp.67~69 (2002)
- Levine S, "Lithium increases body weight of rats: relation to thymolysis", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.155~158 (2006)
- Dempsey M, "Treatement of excessive weight gain in patients taking lithium", Am J Psychiatry, 133, pp.1082~1084 (1976)
- Gracious BL, "Psychotropic-induced weight gain and potential pharmacologic treatment strategies", Psychiatry (Edgmont), 2, pp.36~42 (2005)
- Maayan L, "Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis", Neuropsychopharmacology, 35, pp.1520~1530 (2010)
- Björkhem-Bergman L, "Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis", J Psychopharmacol, 25, pp.299~305 (2011)
- Praharaj SK, "Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis", Br J Clin Pharmacol, 71, pp.377~382 (2011)
- Brufani C, "Systematic review of metformin use in obese nondiabetic children and adolescents", Horm Res Paediatr, 80, pp.78~85 (2013)
- Desilets AR, "Role of metformin for weight management in patients without type 2 diabetes", Ann Pharmacother, 42, pp.817~826 (2008)
- Baxter K, "Stockley’s drug interactions: A source book of interactions, their mechanisms, clinical importance and management" (2010), Pharmaceutical Press
- Malin SK, "Effects of metformin on weight loss:potential mechanisms", Curr Opin Endocrinol Diabetes Obes, 21, pp.323~329 (2014)